19 - Zanubrutinib Versus Ibrutinib in Symptomatic Waldenstrom Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study
episode
TMO EPM / Hemato H9J
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA
Layoffs at the Kansas City Star will hurt local communities
AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health
Planning Commission Meeting - Sep 17, 2026
Heritage Commission - Sep 14, 2026
Historic District Review Committee - Sep 14, 2026